Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma

被引：0
作者：
Junzhe Wang
Xiaoning Song
Xian Zhang
Han Liu
Meirong Zang
Dianwen Qi
Jinqiao Zhang
Lixia Sun
机构：
[1] Hebei Medical University Third Hospital,Department of Hematology
[2] Hebei Medical University Third Hospital,Department of Bone and Soft Tissue Oncology
来源：
Annals of Hematology | 2024年 / 103卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1411 / 1414
页数：3
相关论文
共 50 条
  • [21] Incidence of herpes zoster in transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone
    Horigome, Yuichi
    Kamata, Hirotoshi
    Michishita, Yusuke
    Yokoyama, Maki
    Tadera, Noriyuki
    Hayama, Kei
    Suzuki, Takahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,
  • [22] Management of newly diagnosed transplant ineligible multiple myeloma
    Atrash, Shebli
    Bhutani, Manisha
    Paul, Barry
    Voorhees, Peter M.
    Usmani, Saad Z.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2549 - 2560
  • [23] A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS OF TREATMENTS FOR PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA
    Katja, W.
    Doyen, C.
    Dimopoulos, M. A.
    Yee, A.
    Kropff, M.
    Lahuerta, J. J.
    Martin, A.
    Travers, K.
    Abildgaard, N.
    Lu, J.
    Van Droogenbroeck, J.
    Geraldes, C.
    Petrini, M.
    Voillat, L.
    Vilque, J. -P.
    Voog, E.
    Facon, T.
    HAEMATOLOGICA, 2015, 100 : 250 - 251
  • [24] Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial
    Bahlis, Nizar J.
    Corso, Alessandro
    Mugge, Lars-Olof
    Shen, Zhi-Xiang
    Desjardins, Pierre
    Stoppa, Anne-Marie
    Decaux, Olivier
    De Revel, Thierry
    Granell, Miquel
    Marit, Gerald
    Nahi, Hareth
    Demuynck, Hilde
    Huang, Shang-Yi
    Basu, Supratik
    Guthrie, Troy H.
    Ervin-Haynes, Annette
    Leupin, Nicolas
    Marek, Jennifer
    Chen, Guang
    Facon, Thierry
    BLOOD, 2014, 124 (21)
  • [25] Efficacy of Frontline Treatments for Newly Diagnosed Transplant-Ineligible Multiple Myeloma, a Network Meta-Analysis
    Wong, Maggie
    Wang, Chen
    Soekojo, Cinnie Yentia
    Wong, Hung Chew
    De Mel, Sanjay
    Ooi, Melissa
    Samuel, Miny
    Soon, Yu Yang
    Chng, Wee Joo
    BLOOD, 2022, 140 : 4345 - 4346
  • [26] Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution
    Rodriguez-Lobato, Luis Gerardo
    Tovar, Natalia
    de Daniel, Anna
    de Larrea, Carlos Fernandez
    Cibeira, M. Teresa
    Jimenez-Segura, Raquel
    Moreno, David F.
    Oliver-Caldes, Aina
    Blade, Joan
    Rosinol, Laura
    CANCERS, 2023, 15 (21)
  • [27] Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma
    Wang, Yan
    Liu, Yuan-Fang
    Jin, Shi-Wei
    Tao, Yi
    Zhang, Wei-Ping
    Chen, Jian-Lin
    Jiang, Song-Fu
    Mi, Jian-Qing
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [28] Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Maia Age Subgroup Analysis
    Facon, Thierry
    Kumar, Shaji K.
    Weisel, Katja
    Usmani, Saad
    Moreau, Philippe
    Plesner, Torben
    Orlowski, Robert Z.
    Bahlis, Nizar Jacques
    Basu, Supratik
    Nahi, Hareth
    Hulin, Cyrille
    Quach, Hang
    O'Dwyer, Michael
    Perrot, Aurore
    Venner, Christopher P.
    Raje, Noopur
    Tiab, Mourad
    Macro, Margaret
    Frenzel, Laurent
    Leleu, Xavier
    Pei, Huiling
    Carson, Robin
    Borgsten, Fredrik
    Goldschmidt, Hartmut
    BLOOD, 2022, 140 : 10133 - 10136
  • [29] Treatment Considerations for Transplant-Ineligible Multiple Myeloma
    Elnair, Radowan A.
    Holstein, Sarah A.
    ONCOLOGY-NEW YORK, 2021, 35 (04): : 170 - 182
  • [30] Siltuximab in transplant-ineligible patients with myeloma
    Bagcchi, Sanjeet
    LANCET ONCOLOGY, 2014, 15 (08) : E309 - E309
12345